AIM: To detect the expression of mitochondrial uncoupling protein 2 (UCP2) in colon cancer and analyze the relation between UCP2 expression and clinical pathological features of colon cancer.METHODS: Fifteen colon tis...AIM: To detect the expression of mitochondrial uncoupling protein 2 (UCP2) in colon cancer and analyze the relation between UCP2 expression and clinical pathological features of colon cancer.METHODS: Fifteen colon tissue samples and 15 its adjacent tissue samples were obtained from colon cancer patients during surgical interventions. UCP2 expression was detected with immunohistochemical method in 10 normal controls, 10 hyperplastic polyp patients, 20 tubular adenoma patients and 78 colon cancer patients. Patients with rectal cancer were excluded. Quantitative reverse transcription polymerase chain reaction and Western blotting were used to detect UCP2 expressions in colon cancer tissue samples and its adjacent tissue samples. Relation between UCP2 expression and clinical pathological features of colon cancer was also analyzed. RESULTS: The UCP2 mRNA expression level was fourfold higher in colon cancer tissue samples than in its adjacent tissue samples. The UCP2 protein expression level was three-fold higher in colon cancer tissue samples than in its adjacent normal tissue samples. The UCP2 was mainly expressed in cytoplasm. The UCP2 was not expressed in normal colon mucosa. Strong positive staining for UCP2 with a diffuse distribution pattern was identified throughout the mucosa in colon cancer tissue samples with a positive expression rate of 85.9%. The UCP2 expression level was higher in colon cancer tissue samples at clinical stages Ⅲ and Ⅳ than in those at stageⅠ+ Ⅱ. Univariate analysis showed that the high UCP2 expression level was significantly correlated to colon cancer metastasis (hazard ratio = 4.321, confidence interval = 0.035-0.682, P = 0.046). CONCLUSION: UCP2 is highly expressed in human colon cancer tissue and may be involved in colon cancer metastasis.展开更多
AIM To investigate the role of calmodulin-dependent protein kinase Ⅱ(Ca MKⅡ) in colon cancer growth,migration and invasion.METHODS Ca MKⅡ expression in colon cancer and paracancerous tissues was evaluated via immun...AIM To investigate the role of calmodulin-dependent protein kinase Ⅱ(Ca MKⅡ) in colon cancer growth,migration and invasion.METHODS Ca MKⅡ expression in colon cancer and paracancerous tissues was evaluated via immunochemistry. Transcriptional and posttranscriptional levels of Ca MKⅡin tissue samples and MMP2,MMP9 and TIMP-1 expression in the human colon cancer cell line HCT116 were assessed by q RTPCR and western blot. Cell proliferation was detected with the MTT assay. Cancer cell migration and invasion were investigated with the Transwell culture system and woundhealing assay.RESULTS We first demonstrated that CaMK Ⅱ was ove rexpressed in human colon cancers and was associated with cancer differentiation. In the human colon cancer cell line HCT116,the Ca MKII-specific inhibitor KN93,but not its inactive analogue KN92,decreased cancer cell proliferation. Furthermore,KN93 also significantly prohibited HCT116 cell migration and invasion. The specific inhibition of ERK1/2 or p38 decreased the proliferation and migration of colon cancer cells.CONCLUSION Our findings highlight Ca MKⅡ as a potential critical mediator in human colon tumor development and metastasis.展开更多
Objective:To study the RNF181 and TPX2 expression in colon cancer tissue and their correlation with cancer cell viability and angiogenesis.Methods:Colon cancer tissue and tissue adjacent to carcinoma that were surgica...Objective:To study the RNF181 and TPX2 expression in colon cancer tissue and their correlation with cancer cell viability and angiogenesis.Methods:Colon cancer tissue and tissue adjacent to carcinoma that were surgically removed in our hospital between July 2013 and May 2016 were collected and made into paraffin sections, immunohistochemical staining for RNF181 and TPX2 were conducted, and the positive protein rate was determined;RNA was extracted for fluorescence quantitative PCR reaction, and the mRNA expression of RNF181, TPX2, VEGF, VEGFR1, VEGFR2 and HIF-1α were determined;the preoperative serum samples of colon cancer patients were collected to determine the contents of CEA, CA199 and CA242 levels.Results:mRNA expression and positive protein rate of RNF181 in colon cancer tissue were significantly lower than those in adjacent tissue while mRNA expression and positive protein rate of TPX2 were significantly higher than those in adjacent tissue;CEA, CA199 and CA242 levels in serum as well as VEGF, VEGFR1, VEGFR2 and HIF-1α mRNA expression in colon cancer tissue of patients with positive RNF181 in colon cancer tissue were significantly lower than those of patients with negative RNF181;CEA, CA199 and CA242 levels in serum as well as VEGF, VEGFR1, VEGFR2 and HIF-1α mRNA expression in colon cancer tissue of patients with positive TPX2 in colon cancer tissue were significantly higher than those of patients with negative TPX2.Conclusion: The low expression of RNF181 and high expression of TPX2 in colon cancer tissue are closely related to the cancer cell proliferation and angiogenesis process.展开更多
目的探讨补体C5a/C5aR通路在结肠癌发病中对纤维介素蛋白-2凝血酶原酶(fibrinogen-like protein 2,FGL2)的调节机制,明确补体系统在结肠癌发病中的功能和作用。方法收集2013年12月至2015年7月第三军医大学西南医院普外科、新桥医院消化...目的探讨补体C5a/C5aR通路在结肠癌发病中对纤维介素蛋白-2凝血酶原酶(fibrinogen-like protein 2,FGL2)的调节机制,明确补体系统在结肠癌发病中的功能和作用。方法收集2013年12月至2015年7月第三军医大学西南医院普外科、新桥医院消化科15例经病理活检确诊的住院临床结肠癌患者癌及癌旁组织。采用免疫组织化学方法检测结肠癌患者癌及癌旁组织中补体活化片段C5b-9、活化C3及C5aR的表达,佐证补体系统在结肠癌中的活化状态;进一步通过体内外实验(Western blot)验证结肠癌患者癌及癌旁组织MAPK信号通路中P38的磷酸化水平及FGL2的沉积,明确结肠癌发病中补体C5a/C5aR通路与二者的调节关系。结果免疫组织化学及Western blot实验证实结肠癌患者癌组织C5b-9、活化C3及C5aR的表达明显高于癌旁组织,FGL2的沉积亦显著高于癌旁组织;体外结果提示C5a能促进巨噬细胞系Raw264.7MAPK通路中P38的磷酸化水平(P=0.0013)及FGL2的产生能力(P=0.0071),加入C5aR阻断剂之后,二者表达随之减弱。结论 C5a/C5aR通路能通过MAPK信号途径中的P38信号完成对FGL2的调节作用进而参与结肠癌的发病进程。展开更多
基金Supported by Scientific Research Fund from Jiangsu Province,No.BK2006243National Natural Science Foundation of China,No.30771039
文摘AIM: To detect the expression of mitochondrial uncoupling protein 2 (UCP2) in colon cancer and analyze the relation between UCP2 expression and clinical pathological features of colon cancer.METHODS: Fifteen colon tissue samples and 15 its adjacent tissue samples were obtained from colon cancer patients during surgical interventions. UCP2 expression was detected with immunohistochemical method in 10 normal controls, 10 hyperplastic polyp patients, 20 tubular adenoma patients and 78 colon cancer patients. Patients with rectal cancer were excluded. Quantitative reverse transcription polymerase chain reaction and Western blotting were used to detect UCP2 expressions in colon cancer tissue samples and its adjacent tissue samples. Relation between UCP2 expression and clinical pathological features of colon cancer was also analyzed. RESULTS: The UCP2 mRNA expression level was fourfold higher in colon cancer tissue samples than in its adjacent tissue samples. The UCP2 protein expression level was three-fold higher in colon cancer tissue samples than in its adjacent normal tissue samples. The UCP2 was mainly expressed in cytoplasm. The UCP2 was not expressed in normal colon mucosa. Strong positive staining for UCP2 with a diffuse distribution pattern was identified throughout the mucosa in colon cancer tissue samples with a positive expression rate of 85.9%. The UCP2 expression level was higher in colon cancer tissue samples at clinical stages Ⅲ and Ⅳ than in those at stageⅠ+ Ⅱ. Univariate analysis showed that the high UCP2 expression level was significantly correlated to colon cancer metastasis (hazard ratio = 4.321, confidence interval = 0.035-0.682, P = 0.046). CONCLUSION: UCP2 is highly expressed in human colon cancer tissue and may be involved in colon cancer metastasis.
基金Supported by the National Natural Science Foundation of China,No.81302131
文摘AIM To investigate the role of calmodulin-dependent protein kinase Ⅱ(Ca MKⅡ) in colon cancer growth,migration and invasion.METHODS Ca MKⅡ expression in colon cancer and paracancerous tissues was evaluated via immunochemistry. Transcriptional and posttranscriptional levels of Ca MKⅡin tissue samples and MMP2,MMP9 and TIMP-1 expression in the human colon cancer cell line HCT116 were assessed by q RTPCR and western blot. Cell proliferation was detected with the MTT assay. Cancer cell migration and invasion were investigated with the Transwell culture system and woundhealing assay.RESULTS We first demonstrated that CaMK Ⅱ was ove rexpressed in human colon cancers and was associated with cancer differentiation. In the human colon cancer cell line HCT116,the Ca MKII-specific inhibitor KN93,but not its inactive analogue KN92,decreased cancer cell proliferation. Furthermore,KN93 also significantly prohibited HCT116 cell migration and invasion. The specific inhibition of ERK1/2 or p38 decreased the proliferation and migration of colon cancer cells.CONCLUSION Our findings highlight Ca MKⅡ as a potential critical mediator in human colon tumor development and metastasis.
文摘Objective:To study the RNF181 and TPX2 expression in colon cancer tissue and their correlation with cancer cell viability and angiogenesis.Methods:Colon cancer tissue and tissue adjacent to carcinoma that were surgically removed in our hospital between July 2013 and May 2016 were collected and made into paraffin sections, immunohistochemical staining for RNF181 and TPX2 were conducted, and the positive protein rate was determined;RNA was extracted for fluorescence quantitative PCR reaction, and the mRNA expression of RNF181, TPX2, VEGF, VEGFR1, VEGFR2 and HIF-1α were determined;the preoperative serum samples of colon cancer patients were collected to determine the contents of CEA, CA199 and CA242 levels.Results:mRNA expression and positive protein rate of RNF181 in colon cancer tissue were significantly lower than those in adjacent tissue while mRNA expression and positive protein rate of TPX2 were significantly higher than those in adjacent tissue;CEA, CA199 and CA242 levels in serum as well as VEGF, VEGFR1, VEGFR2 and HIF-1α mRNA expression in colon cancer tissue of patients with positive RNF181 in colon cancer tissue were significantly lower than those of patients with negative RNF181;CEA, CA199 and CA242 levels in serum as well as VEGF, VEGFR1, VEGFR2 and HIF-1α mRNA expression in colon cancer tissue of patients with positive TPX2 in colon cancer tissue were significantly higher than those of patients with negative TPX2.Conclusion: The low expression of RNF181 and high expression of TPX2 in colon cancer tissue are closely related to the cancer cell proliferation and angiogenesis process.
